You can read the full July 17 print issue of Chain Drug Review in its entirety here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!
DEERFIELD, Ill. — In December 2020, Walgreens made its debut in the fast-growing retail advertising field with the launch of Walgreens Advertising Group (wag). The move was timely: A recent study by Morgan Stanley estimates that retail advertising generated $80 billion last year (excluding China) and will reach $130 billion in revenue by 2025. However,
In a retail pharmacy, between the food and beverage aisles and the prescription drugs, consumers can find two kinds of health products: over-the-counter medicines and nutraceuticals. These two products could not be any more different from each other when it comes to their market landscape, the degree of innovation happening and the implications for retail
PRINCETON, N.J. — With the end of the public health emergency, Dr. Reddy’s Laboratories has assessed the pandemic’s effect on its interactions with drug chains and how the COVID years will impact future relationships. In an interview with Chain Drug Review, senior director of Rx marketing Christine Walton discussed the past, present and future of
Biologics are changing the way we treat disease, affecting where companies invest and, most importantly, impacting patients’ lives. Last year, nearly half of the 37 new drugs approved by the Center for Drug Evaluation and Research (CDER) were biologics, while its partner agency — the Center for Biologics Evaluation and Research (CBER) — approved a
It’s well known that beyond their role in filling prescriptions as an essential link between health care providers and patients, retail pharmacies have long offered a broad range of products aimed at helping people to maintain their health. More recently, drug stores have made significant advancements into the provider realm by offering services like minute
BENTONVILLE, Ark. — Walmart has taken several significant steps to heighten the impact of its pharmacists on the health and well-being of Americans. The moves, including higher compensation for those professionals (as well as the company’s opticians) and the rollout of dozens of additional HIV-focused Specialty Pharmacies of the Community (SPOCs), are the latest signs
Make no mistake: In mass retailing, as in other fields of endeavor, this is truly the Age of the Woman. Forget the stories that name the 10, 20 or even 50 most important women in mass retailing. Women have gone far beyond that. Indeed, they have come to exert an impact on the mass retailing
